The Federal Reserve's third interest rate cut of the year will likely have consequences for debt, savings, auto loans, mortgages and other forms of borrowing by consumers and businesses. The policymakers now envision two rate cuts next year, not the four they predicted back in September. Loan rates may barely budge if the Fed sticks with its plan to cut its key short-term rate only twice next year.
Jefferies initiated a "buy" rating on Rocket Pharmaceuticals, based on the biotech firm's experimental gene therapies.
Zach Jecklin of Echo Global Logistics discusses the importance of providing good service through difficult freight markets, Echo’s strategy to leverage AI and how technology can help maintain relationships without eliminating human oversight. The post Focus on relationships is the key to navigating market downturns appeared first on FreightWaves.
The Federal Reserve adjusted a key part of its rate control toolkit on Wednesday, lowering the rate it offers on its reverse repo facility by more than it cut the federal funds rate. The Fed said that the reverse repo rate will now stand at 4.25% from its prior level of 4.55%, marking a 30 basis point easing, while it lowered the federal funds target rate range by a quarter percentage point to between 4.25% and 4.5%. Analysts believe the largely expected adjustment is a bid by the Fed to nudge cash out of a facility that’s widely viewed as a proxy for excessive liquidity in the financial system.
U.S. central bankers on Wednesday issued fresh projections calling for two quarter-point interest-rate cuts next year amid rising inflation, a forecast consistent with a wait-and-see approach come January as Donald Trump starts his second four-year stint in the White House. The Federal Reserve's latest quarterly summary of economic projections shows policymakers expect inflation by the Fed's targeted metric to end this year at 2.4% and 2025 at 2.5%. The fresh forecasts imply a shift to a far more cautious pace of rate cuts in the new year after Fed policymakers delivered a third straight reduction in short-term borrowing costs at the close of their Dec. 17-18 meeting.
The best way for most investors to approach this type of market is to stick to the long-term plan.
(Bloomberg) -- Here are key takeaways from the Federal Reserve’s interest-rate decision on Wednesday:Most Read from BloombergNYPD Car Chases Are Becoming More Frequent — and More DangerousFederal Open Market Committee votes 11-1 to lower benchmark rate by 25 basis points to target range of 4.25%-4.5%Cleveland Fed President Beth Hammack votes against decision in favor holding rates steady, the second such dissent since the Fed began lowering rates in September“Dot plot” of rate projections shows
An investment firm's analysts compile a list of their top tech recommendations for the coming year.
US benchmark equity indexes were higher ahead of the Federal Reserve's latest monetary policy decisi
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The trial will enroll 64 patients with moderate to severe atopic dermatitis who previously failed one prior topical or systemic therapy. These doses were selected based on the company’s prior experience evaluating soquelitinib in T-cell lymphoma patients. The company is reporting complete results from Cohort 1 of the trial, which inc
